Clinical trials: Hemianopia, Homonymous
Hemianopia, Homonymous, Hemianopsia, Homonymous
VR System for Cross-modal Rehabilitation of Hemianopia
The purpose of this research study is to investigate the effectiveness of a new rehabilitation for visual hemianopia. The study team believes a cross-modal rehabilitation technique delivered by a virtual reality system can help…
- Trial name
- NCT04230486
- Testing
- Cross-model Visual Auditory Rehabilitation
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Wake Forest University Health Sciences
Acute Stroke, Visual Field Loss
Fluoxetine for Visual Recovery After Ischemic Stroke
The purpose of this study is to determine whether fluoxetine, a selective serotonin reuptake inhibitor commonly used for depression, enhances visual recovery after an acute ischemic stroke.
- Trial name
- FLUORESCE (NCT02737930)
- Testing
- Fluoxetine
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Bogachan Sahin
Homonymous Hemianopia
Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia
This clinical trial will evaluate the efficacy of two types of high-power prism glasses that provide field of view expansion for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side…
- Trial name
- NCT04827147
- Testing
- Multi-Periscopic Prism (MPP) glasses, Fresnel Peripheral Prism (FPP) glasses
- Where
- 8 sites in United States
- Volunteers
- 64 people
- Sponsor
- Massachusetts Eye and Ear Infirmary
Homonymous Hemianopia, Homonymous Quadrantanopia
Reminder-cue Scanning Training for Homonymous Visual Field Loss
This study will evaluate a new approach to training people with visual field loss to scan when driving
- Trial name
- NCT06136169
- Testing
- Reminder-cue scanning training
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- Massachusetts Eye and Ear Infirmary
Homonymous Hemianopia
Clinical Trial of Peripheral Prism Glasses for Hemianopia
The purpose of this study is to evaluate the functional utility for general mobility (walking) of new high power permanent peripheral prism glasses, which provide visual field expansion device for patients with homonymous…
- Trial name
- NCT00494676
- Testing
- High power (57 prism diopter) peripheral prism glasses
- Where
- 13 sites in United States, United Kingdom
- Volunteers
- 73 people
- Sponsor
- Alexandra Bowers